Retatrutide groups: ~ 75% reduction in WOMAC pain score Placebo group: 40.3% reduction [9] Comparison With Other Medications Semaglutide (Ozempic) 68-week trial ~15% average weight loss In overweight/obese participants without diabetes [10] Tirzepatide 72-week trial Highest dose (15 mg): ~ 21% average weight loss 2,539 participants without diabetes [11] Takeaway Retatrutide clearly sets a new bar for weight loss effectiveness but thats not the full story
If you are planning to become pregnant, you should discuss alternative treatment options with your healthcare provider well before conception
For prescribers and patients navigating this landscape, the ProRx case highlights the broader risks that come with sourcing compounded versions of high-demand drugs
Other splicing factors have also been identified as being involved through other genetic screens or directly testing for potential involvement, including mog-1, mog-4, mog-5 (masculinization of germline) , cyn-4/mog-6 and prp-19 (Puoti and Kimble, 1999
Authoritative Sources For complete labeled dosing, warnings, contraindications, and administration instructions, see the Official prescribing information